All In Biotech

Free tool

FAERS Monitor: Bacteriostatic Water For Injection In Plastic Container

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018802 or its brand name (Bacteriostatic Water For Injection In Plastic Container, Sterile Water For Injection). Reports on generic versions are filed under their own applications.

Reports

415

Serious

172

41% of reports

Hospitalization

102

Death reported

12

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • product dose omission issue78
  • weight increased43
  • weight decreased39
  • headache33
  • therapy interrupted33
  • off label use28
  • pain28
  • drug ineffective24
  • decreased appetite20
  • fatigue17
  • hospitalisation17
  • blood glucose increased16
  • inappropriate schedule of product administration16
  • injection site pain16
  • covid-1915

Reports by year received

View as table
YearReports
20132
20151
20162
20172
20182
20199
202055
202143
202257
202358
202471
202549
202664

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,744 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
therapy interruptedSignal3323.416.9688
product dose omission issueSignal7813.411.0899
weight increasedSignal439.77.3332
weight decreasedSignal397.15.3200
hospitalisationSignal175.63.560
inappropriate schedule of product administrationSignal164.52.840
decreased appetiteSignal204.42.849
covid-19Signal154.32.635
blood glucose increasedSignal164.32.738
headacheSignal332.71.934
injection site painSignal162.61.615
painSignal282.31.620
off label use281.61.16
fatigue171.10.70
drug ineffective240.90.60

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.